Diabetic Nephropathy Serum

About Diabetic Nephropathy Serum

Diabetic Nephropathy Serum for Diabetic Kidney Disease Research

Our Diabetic Nephropathy Serum is sourced from IRB-consented donors clinically diagnosed with diabetic nephropathy. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality. Diabetic nephropathy is a microvascular complication of diabetes in which sustained hyperglycaemia, haemodynamic stress and metabolic injury damage the glomerular filtration barrier, producing progressive albuminuria and loss of filtration function. This serum supports nephrology biomarker discovery, renal function assay development and therapeutic research.

Glomerular Injury, Renal Function Biology and Why Serum

• Chronic hyperglycaemia drives advanced glycation end-product formation, oxidative stress and haemodynamic changes that injure podocytes, mesangial cells and the glomerular endothelium — a metabolic microvascular process, not autoimmunity.
• Structural hallmarks include glomerular basement membrane thickening, mesangial expansion and podocyte loss, which together degrade the filtration barrier and permit albumin leakage.
• Loss of filtration capacity raises circulating creatinine and cystatin C, the analytes underlying estimated glomerular filtration rate; both are measured in serum, making serum the standard matrix for renal function work.
• Progressive disease is accompanied by secondary changes measurable in serum, including altered mineral and bone metabolism markers, anaemia-related indices and rising inflammatory and fibrosis-associated mediators.
• Established renin–angiotensin system blockade and newer SGLT2 inhibitor and mineralocorticoid receptor antagonist therapies make treatment-stratified serum valuable for pharmacodynamic and biomarker work.
• Serum is acellular. It suits clinical chemistry, immunoassay, proteomic and metabolomic analysis; no cell-based or immunophenotyping assays are performed on this matrix.

Donor Stratification Available

• CKD stage by eGFR category where documented
• Albuminuria category by urine albumin-to-creatinine ratio where documented
• Underlying diabetes type: type 1 versus type 2 diabetes
• Glycaemic control as reflected in documented HbA1c
• Treatment status: ACE inhibitor or ARB, SGLT2 inhibitor, mineralocorticoid receptor antagonist, GLP-1 receptor agonist, or untreated
• Diabetes duration and presence of other microvascular complications such as retinopathy or neuropathy
• Matched healthy controls available, including diabetic donors without nephropathy

Product Features

• Collected from clinically confirmed diabetic nephropathy donors
• Processed and frozen within 24 hours of collection
• Research Use Only (RUO)
• IRB-approved protocols with documented consent
• Custom aliquot volumes available upon request

De-identified Donor Data

• Diagnosis confirmation
• Age, sex assigned at birth, and ethnicity
• Donor-reported medical history and comorbidities
• Renal function and glycaemic laboratory values where available
• Concurrent medications, including renoprotective therapy where reported

Applications

• Creatinine and cystatin C assay development and eGFR method comparison
• Biomarker discovery for progression of diabetic kidney disease
• Serum cytokine, chemokine and fibrosis-associated mediator profiling
• Advanced glycation end-product and oxidative stress marker research
• Serum proteomic and metabolomic discovery studies
• Mineral and bone metabolism marker characterisation in progressive CKD
• Pharmacodynamic and treatment response research for renoprotective therapies
• Clinical chemistry assay validation across impaired renal function ranges

Other Diabetic Nephropathy Specimen Types

• Diabetic Nephropathy Plasma
• Diabetic Nephropathy Whole Blood
• Diabetic Nephropathy PBMC
• Diabetic Nephropathy Leukopak

Compliance and Quality Assurance

• IRB-approved and HIPAA-compliant protocols
• Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
• Documentation support available for regulatory review

Ordering & Customization

Diabetic nephropathy serum is available in standard and custom volumes. For pricing, current availability, international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations. To browse donor cohorts across our full inventory, visit our human serum page.